Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL115527 | 0.97 | LMNA (0.47) | LMNAADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL6376885 | 0.92 | LMNA (0.43) | LMNAADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL27859745 | 0.92 | DNM1 (0.48) | LMNAADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL8766929 | 0.89 | LMNA (0.41) | LMNAADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL1426655 | 0.89 | LMNA (0.63) | LMNAADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL28557811 | 0.88 | DNM1 (0.50) | LMNADNM1TSHRALDH1A1CA1 | |
| SCHEMBL6122979 | 0.86 | ADRB2 (0.39) | LMNAADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL873400 | 0.86 | DNM1 (0.54) | LMNADNM1TSHRTHRB | |
| SCHEMBL6686359 | 0.86 | DNM1 (0.54) | LMNADNM1TSHRTHRB | |
| SCHEMBL16841236 | 0.86 | DNM1 (0.54) | LMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398166-B2 | Method of selectively forming cobalt metal layer by using cobalt compound, and method of fabricating semiconductor device by using cobalt compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-08-26 | — | — | US | disclosed |
| US-20230257409-A1 | METHOD OF SELECTIVELY FORMING COBALT METAL LAYER BY USING COBALT COMPOUND, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE BY USING COBALT COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398166-B2 | Method of selectively forming cobalt metal layer by using cobalt compound, and method of fabricating semiconductor device by using cobalt compound | SCO2, CNOT9, CNOT1 | LMNA 4233/4885ADRB2 4728/4885ADRB1 4791/4885 |
| US-20230257409-A1 | METHOD OF SELECTIVELY FORMING COBALT METAL LAYER BY USING COBALT COMPOUND, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE BY USING COBALT COMPOUND | SCO2, CNOT9, CNOT1 | LMNA 4233/4885ADRB2 4728/4885ADRB1 4791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.